TOP TEN perturbations for 38378_at (Homo sapiens)
Organism: Homo sapiens
Gene: 38378_at
Selected probe(set): 203416_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 38378_at (203416_at) across 6674 perturbations tested by GENEVESTIGATOR:
expO ovary cancer study 1 (granulosa cell tumor, malignant; metastatic) / expO ovary cancer study 1 (dysgerminoma; metastatic)
Relative Expression (log2-ratio):-4.894575Number of Samples:2 / 2
| Experimental | expO ovary cancer study 1 (granulosa cell tumor, malignant; metastatic) |
| Metastatic tumor tissue samples obtained from patients with primary granulosa cell tumor of the ovary. | |
| Control | expO ovary cancer study 1 (dysgerminoma; metastatic) |
| Metastatic tumor tissue samples obtained from patients with primary dysgerminoma of the ovary. |
cutaneous T-cell lymphoma study 1 (tumor phase) / normal skin tissue
Relative Expression (log2-ratio):4.187931Number of Samples:4 / 8
| Experimental | cutaneous T-cell lymphoma study 1 (tumor phase) |
| Lesional skin biopsies from patients with cutaneous T-cell lymphoma in the tumor phase (extranodal). | |
| Control | normal skin tissue |
| Skin biopsies from healthy individuals. |
oligodendrocyte progenitor cell study 2 (O4-;CD140a+) / oligodendrocyte progenitor cell study 2 (O4-;CD140a-)
Relative Expression (log2-ratio):4.1797085Number of Samples:5 / 5
| Experimental | oligodendrocyte progenitor cell study 2 (O4-;CD140a+) |
| Fetal oligodendrocyte cells between 20-22wk gestational age derived from fetal brains were FACS sorted on the basis of CD140a (PDGFRA) antigens. Samples were O4-/CD140a+. | |
| Control | oligodendrocyte progenitor cell study 2 (O4-;CD140a-) |
| Fetal oligodendrocyte cells between 20-22wk gestational age derived from fetal brains were FACS sorted on the basis of CD140a (PDGFRA) antigens. Samples were O4-/CD140a-. |
renal cell carcinoma study 4 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):3.7436714Number of Samples:26 / 2
| Experimental | renal cell carcinoma study 4 |
| Tumor tissue samples from the kidney of patients with renal cell carcinoma (RCC). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |
lung adenocarcinoma study 9 (metastase; lymph node) / lung adenocarcinoma study 9 (metastase; brain)
Relative Expression (log2-ratio):3.683403Number of Samples:3 / 6
| Experimental | lung adenocarcinoma study 9 (metastase; lymph node) |
| Metastatic tumor tissue obtained from the lymph node of patients with primary lung adenocarcinoma. | |
| Control | lung adenocarcinoma study 9 (metastase; brain) |
| Metastatic tumor tissue obtained from the brain of patients with primary lung adenocarcinoma. |
Sjogren's syndrome study 2 (pSS) / Sjogren's syndrome study 2 (non-pSS)
Relative Expression (log2-ratio):3.6307144Number of Samples:7 / 14
| Experimental | Sjogren's syndrome study 2 (pSS) |
| Incisional biopsy of one parotid gland of patients who fulfilled the 2002 AECG criteria for primary Sjogren's syndrome (pSS). Patients were at least 21 years old. | |
| Control | Sjogren's syndrome study 2 (non-pSS) |
| Incisional biopsy of one parotid gland of patients with Sicca-syndrome who did not fulfill the 2002 AECG criteria for primary Sjogren's syndrome (non-pSS Sicca). Patients were at least 21 years old. |
retina pigment epithelium study 1 (adult) / retina pigment epithelium study 1 (fetal)
Relative Expression (log2-ratio):3.586381Number of Samples:2 / 6
| Experimental | retina pigment epithelium study 1 (adult) |
| Postmortem human native retina pigment epithelium samples from adult individuals. | |
| Control | retina pigment epithelium study 1 (fetal) |
| Human native fetal retina pigment epithelium samples obtained at gestation age between week 16-18. |
HIV-associated neurocognitive disorder study 4 (minimal) / normal genu sample
Relative Expression (log2-ratio):3.5371494Number of Samples:2 / 8
| Experimental | HIV-associated neurocognitive disorder study 4 (minimal) |
| Postmortem brain samples of the centrum semiovale (deep white matter) at the coronal level of the genu of the corpus callosum from patients with minimal histopathological changes including trivial microscopic abnormalities, atherosclerosis and minimal perivascular inflammation. The patients did not receive any antiretroviral therapy (ART). | |
| Control | normal genu sample |
| Postmortem brain samples of the centrum semiovale (deep white matter) at the coronal level of the genu of the corpus callosum from healthy subjects. |
inclusion body myositis study 2 / normal quadriceps tissue
Relative Expression (log2-ratio):3.522708Number of Samples:5 / 2
| Experimental | inclusion body myositis study 2 |
| Quadriceps femoris biopsy muscle samples from patients with clinical diagnosis of inclusion body myositis (IBM). | |
| Control | normal quadriceps tissue |
| Quadriceps femoris biopsy muscle samples from control subjects. |
collecting duct carcinoma study 1 / normal kidney tissue (fetal)
Relative Expression (log2-ratio):3.5170527Number of Samples:2 / 2
| Experimental | collecting duct carcinoma study 1 |
| Tumor tissue samples from the kidney of patients with collecting duct carcinoma (CDC). | |
| Control | normal kidney tissue (fetal) |
| Normal fetal kidney tissue samples. |